z-logo
open-access-imgOpen Access
Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer
Author(s) -
Chao Zhu,
Yunhong You,
Keke Nie,
Youxin Ji
Publication year - 2019
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000196
Subject(s) - medicine , osimertinib , lung cancer , epidermal growth factor receptor , erlotinib , adenocarcinoma , gefitinib , pleural effusion , lung , pathology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here